LitAlert ~~ GeneLit.com

    • Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review.
    • Liberto JM, Chen SY, Shih IM, Wang TH, Wang TL, Pisanic TRR.
    • Cancers (Basel). 2022 Jun 11;14(12):2885. doi: 10.3390/cancers14122885.
    • Optimal breast cancer risk reduction policies tailored to personal risk level.
    • Ergun MA, Hajjar A, Alagoz O, Rampurwala M.
    • Health Care Manag Sci. 2022 Jun 10. doi: 10.1007/s10729-022-09596-2. Epub ahead of print.
    • Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviews.
    • Mittendorf KF, Lewis HS, Duenas DM, Eubanks DJ, Gilmore MJ, Goddard KAB, Joseph G, Kauffman TL, Kraft SA, Lindberg NM, Reyes AA, Shuster E, Syngal S, Ukaegbu C, Zepp JM, Wilfond BS, Porter KM.
    • Hered Cancer Clin Pract. 2022 Jun 10;20(1):22. doi: 10.1186/s13053-022-00231-3.
    • RAD21 confers poor prognosis and affects ovarian cancer sensitivity to PARP inhibitors through DNA damage repair.
    • Gou R, Li X, Dong H, Hu Y, Liu O, Liu J, Lin B.
    • Front Oncol. 2022 Jun 9;12:936550. doi: 10.3389/fonc.2022.936550.
    • Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer.
    • Heald B, Mokhtary S, Nielsen SM, Rojahn S, Yang S, Michalski ST, Esplin ED.
    • Gynecol Oncol. 2022 Jun 9:S0090-8258(22)00334-1. doi: 10.1016/j.ygyno.2022.05.023. Epub ahead of print.